Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109674601000001115 | Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109674701000001113 | Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials | Is a | Product containing lidocaine and methylprednisolone | false | Inferred relationship | Existential restriction modifier | ||
| Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials | Has active ingredient | Methylprednisolone | false | Inferred relationship | Existential restriction modifier | ||
| Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials | Has active ingredient | Lidocaine | false | Inferred relationship | Existential restriction modifier | ||
| Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials | Has dispensed dose form | Conventional release suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials | Has specific active ingredient | Methylprednisolone acetate | false | Inferred relationship | Existential restriction modifier | ||
| Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials | Has specific active ingredient | Lidocaine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR